Clinical Science Research and Development Service; Cooperative Studies Scientific Evaluation Committee; Notice of Meeting, 72910 [E8-28436]

Download as PDF 72910 Federal Register / Vol. 73, No. 231 / Monday, December 1, 2008 / Notices DEPARTMENT OF TRANSPORTATION Surface Transportation Board [STB Finance Docket No. 35200] Union Pacific Railroad Company— Temporary Trackage Rights Exemption—BNSF Railway Company Pursuant to a written trackage rights agreement, BNSF Railway Company (BNSF) has agreed to grant temporary overhead trackage rights to Union Pacific Railroad Company (UP) over BNSF’s lines of railroad between Basta, CA (milepost 163.15), and Fullerton, CA (milepost 165.23), a distance of approximately 2 miles. The transaction is scheduled to be consummated on December 17, 2008, and the temporary trackage rights will expire on or about January 26, 2009.1 The purpose of the temporary trackage rights is to facilitate maintenance work on UP lines. As a condition to this exemption, any employees affected by the acquisition of the temporary trackage rights will be protected by the conditions imposed in Norfolk and Western Ry. Co.—Trackage Rights—BN, 354 I.C.C. 605 (1978), as modified in Mendocino Coast Ry., Inc.— Lease and Operate, 360 I.C.C. 653 (1980), and any employees affected by the discontinuance of those trackage rights will be protected by the conditions set out in Oregon Short Line R. Co.—Abandonment—Goshen, 360 I.C.C. 91 (1979). Pursuant to the Consolidated Appropriations Act, 2008, Public Law No. 110–161, § 193, 121 Stat. 1844 (2007), nothing in this decision authorizes the following activities at any solid waste rail transfer facility: collecting, storing, or transferring solid waste outside of its original shipping container; or separating or processing solid waste (including baling, crushing, rwilkins on PROD1PC63 with NOTICES 1 UP states that, under section 2 of the trackage rights agreement, BNSF may consider extending the time frame if conditions allow. VerDate Aug<31>2005 16:47 Nov 28, 2008 Jkt 217001 compacting, and shredding). The term ‘‘solid waste’’ is defined in section 1004 of the Solid Waste Disposal Act, 42 U.S.C. 6903. This notice is filed under 49 CFR 1180.2(d)(8). If it contains false or misleading information, the exemption is void ab initio. Petitions to revoke the exemption under 49 U.S.C. 10502(d) may be filed at any time. The filing of a petition to revoke will not automatically stay the transaction. Petitions for stay must be filed by December 10, 2008 (at least 7 days before the exemption becomes effective). An original and 10 copies of all pleadings, referring to STB Finance Docket No. 35200, must be filed with the Surface Transportation Board, 395 E Street, SW., Washington, DC 20423– 0001. In addition, a copy of each pleading must be served on Gabriel S. Meyer, Assistant General Attorney, 1400 Douglas Street, STOP 1580, Omaha, NE 68179. Board decisions and notices are available on our Web site at https:// www.stb.dot.gov. Decided: November 21, 2008. By the Board, David M. Konschnik, Director, Office of Proceedings. Jeff Herzig, Clearance Clerk. [FR Doc. E8–28256 Filed 11–28–08; 8:45 am] BILLING CODE 4915–01–P DEPARTMENT OF VETERANS AFFAIRS Clinical Science Research and Development Service; Cooperative Studies Scientific Evaluation Committee; Notice of Meeting The Department of Veterans Affairs (VA) gives notice under Public Law 92– 463 (Federal Advisory Committee Act) that a meeting of the Clinical Science Research and Development Service Cooperative Studies Scientific PO 00000 Frm 00150 Fmt 4703 Sfmt 4703 Evaluation Committee will be held on January 7, 2009, at the St. Gregory Hotel, 2033 M Street, NW., Washington, DC. The session is scheduled to begin at 8 a.m. and end at 4 p.m. The Committee advises the Chief Research and Development Officer through the Director of the Clinical Science Research and Development Service on the relevance and feasibility of proposed projects and the scientific validity and propriety of technical details, including protection of human subjects. The session will be open to the public for approximately 30 minutes at the start of the meeting for the discussion of administrative matters and the general status of the program. The remaining portion of the session will be closed to the public for the Committee’s review, discussion and evaluation of research and development applications. During the closed portion of the meeting, discussions and recommendations will deal with qualifications of personnel conducting the studies, staff and consultant critiques of research proposals and similar documents and the medical records of patients who are study subjects, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. As provided by section 10(d) of Public Law 92–463, as amended, closing portions of this meeting is in accordance with 5 U.S.C. 552b(c)(6) and (c)(9)(B). Those who plan to attend should contact Dr. Grant Huang, Deputy Director, Cooperative Studies Program (125), Department of Veterans Affairs, 810 Vermont Avenue, NW., Washington, DC 20420, at (202) 461– 1700. Dated: November 24, 2008. By Direction of the Secretary. E. Philip Riggin, Committee Management Officer. [FR Doc. E8–28436 Filed 11–28–08; 8:45 am] BILLING CODE 8320–01–P E:\FR\FM\01DEN1.SGM 01DEN1

Agencies

[Federal Register Volume 73, Number 231 (Monday, December 1, 2008)]
[Notices]
[Page 72910]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-28436]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Clinical Science Research and Development Service; Cooperative 
Studies Scientific Evaluation Committee; Notice of Meeting

    The Department of Veterans Affairs (VA) gives notice under Public 
Law 92-463 (Federal Advisory Committee Act) that a meeting of the 
Clinical Science Research and Development Service Cooperative Studies 
Scientific Evaluation Committee will be held on January 7, 2009, at the 
St. Gregory Hotel, 2033 M Street, NW., Washington, DC. The session is 
scheduled to begin at 8 a.m. and end at 4 p.m.
    The Committee advises the Chief Research and Development Officer 
through the Director of the Clinical Science Research and Development 
Service on the relevance and feasibility of proposed projects and the 
scientific validity and propriety of technical details, including 
protection of human subjects.
    The session will be open to the public for approximately 30 minutes 
at the start of the meeting for the discussion of administrative 
matters and the general status of the program. The remaining portion of 
the session will be closed to the public for the Committee's review, 
discussion and evaluation of research and development applications.
    During the closed portion of the meeting, discussions and 
recommendations will deal with qualifications of personnel conducting 
the studies, staff and consultant critiques of research proposals and 
similar documents and the medical records of patients who are study 
subjects, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy. As provided by section 10(d) 
of Public Law 92-463, as amended, closing portions of this meeting is 
in accordance with 5 U.S.C. 552b(c)(6) and (c)(9)(B).
    Those who plan to attend should contact Dr. Grant Huang, Deputy 
Director, Cooperative Studies Program (125), Department of Veterans 
Affairs, 810 Vermont Avenue, NW., Washington, DC 20420, at (202) 461-
1700.

    Dated: November 24, 2008.

    By Direction of the Secretary.
E. Philip Riggin,
Committee Management Officer.
 [FR Doc. E8-28436 Filed 11-28-08; 8:45 am]
BILLING CODE 8320-01-P